| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM1 TPM2 TPM3 KIF21B MYH1 CENPE SYNE1 KIF21A PPP1R9A CEP290 SPAG5 MSN KIF15 MACO1 WASF2 TAOK1 CALML4 SKA3 UTRN NIN | 2.45e-06 | 1099 | 111 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.53e-06 | 70 | 111 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.30e-06 | 118 | 111 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | microtubule binding | 5.61e-05 | 308 | 111 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.38e-04 | 428 | 111 | 10 | GO:0015631 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B TTF2 MYH1 CENPE KIF21A DNAH7 KIF15 DDX21 DDX24 DHX29 DNAH9 TOP2B | 1.58e-04 | 614 | 111 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 8.39e-04 | 8 | 111 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 8.39e-04 | 8 | 111 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | protein domain specific binding | TPM1 WBP11 ERC1 KIF21A PPP1R9A TFDP3 SKIL TFDP1 TFDP2 WASF2 SSX2IP CDC5L TOP1 | 1.14e-03 | 875 | 111 | 13 | GO:0019904 |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.19e-03 | 83 | 111 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | actin binding | 1.42e-03 | 479 | 111 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.70e-03 | 227 | 111 | 6 | GO:0051015 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KIF21B CCP110 CENPE SPEF2 KIF21A SDCCAG8 CEP290 DNAH7 SPAG5 KIF15 GCC2 SSX2IP TAOK1 CKAP2 SKA3 CCDC102B DNAH9 CFAP53 AP3D1 DEUP1 NIN | 1.37e-07 | 1058 | 109 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCP110 CENPE SPEF2 SDCCAG8 CEP290 DNAH7 SPAG5 KIF15 GCC2 SSX2IP TAOK1 CKAP2 SKA3 CCDC102B DEUP1 NIN | 1.19e-06 | 720 | 109 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 4.96e-06 | 179 | 109 | 8 | GO:0031023 | |
| GeneOntologyBiologicalProcess | cell cycle process | ANKRD31 CCP110 ERCC4 CENPE C9orf78 SDCCAG8 TFDP3 TFDP1 SPAG5 MEN1 KIF15 SSX2IP TAOK1 CKAP2 CDC5L SKA3 CCDC102B TOP1 TOP2B DEUP1 MYBL1 NIN | 5.39e-06 | 1441 | 109 | 22 | GO:0022402 |
| GeneOntologyBiologicalProcess | centrosome cycle | 2.67e-05 | 164 | 109 | 7 | GO:0007098 | |
| GeneOntologyBiologicalProcess | organelle assembly | TPM1 CCP110 CENPE SYNE1 SPEF2 SDCCAG8 CEP290 PTPN23 DNAH7 SPAG5 MSN CC2D2B KIF15 SSX2IP DHX29 CFAP53 AP3D1 DEUP1 | 2.76e-05 | 1138 | 109 | 18 | GO:0070925 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | TPM1 CCP110 ERCC4 CENPE PPP1R9A PARP1 WASF2 PAK2 TAOK1 CKAP2 | 7.96e-05 | 421 | 109 | 10 | GO:0010639 |
| GeneOntologyBiologicalProcess | rRNA metabolic process | 1.07e-04 | 275 | 109 | 8 | GO:0016072 | |
| GeneOntologyBiologicalProcess | cilium assembly | CCP110 SYNE1 SPEF2 SDCCAG8 CEP290 PTPN23 DNAH7 CC2D2B SSX2IP CFAP53 | 1.23e-04 | 444 | 109 | 10 | GO:0060271 |
| GeneOntologyBiologicalProcess | meiosis I | 1.31e-04 | 147 | 109 | 6 | GO:0007127 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 1.53e-04 | 20 | 109 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 1.75e-04 | 155 | 109 | 6 | GO:0061982 | |
| GeneOntologyBiologicalProcess | cilium organization | CCP110 SYNE1 SPEF2 SDCCAG8 CEP290 PTPN23 DNAH7 CC2D2B SSX2IP CFAP53 | 2.16e-04 | 476 | 109 | 10 | GO:0044782 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | CCP110 SYNE1 SPEF2 SDCCAG8 PPP1R9A CEP290 PTPN23 DNAH7 CC2D2B WASF2 SSX2IP CFAP53 | 2.21e-04 | 670 | 109 | 12 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | CCP110 SYNE1 SPEF2 SDCCAG8 PPP1R9A CEP290 PTPN23 DNAH7 CC2D2B WASF2 SSX2IP CFAP53 | 2.70e-04 | 685 | 109 | 12 | GO:0030031 |
| GeneOntologyBiologicalProcess | microtubule-based movement | KIF21B CENPE SPEF2 KIF21A DNAH7 KIF15 SSX2IP DNAH9 CFAP53 AP3D1 | 2.86e-04 | 493 | 109 | 10 | GO:0007018 |
| GeneOntologyBiologicalProcess | maintenance of presynaptic active zone structure | 4.09e-04 | 6 | 109 | 2 | GO:0048790 | |
| GeneOntologyCellularComponent | muscle thin filament tropomyosin | 5.65e-07 | 4 | 110 | 3 | GO:0005862 | |
| GeneOntologyCellularComponent | microtubule organizing center | CCP110 CDKL2 DIS3L CEP85L ERC1 SDCCAG8 CEP290 PTPN23 CCDC141 SPAG5 KIF15 SSX2IP CKAP2 SKA3 CCDC102B CFAP53 DEUP1 NIN | 1.40e-06 | 919 | 110 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | centrosome | CCP110 CDKL2 DIS3L CEP85L ERC1 SDCCAG8 CEP290 CCDC141 SPAG5 KIF15 SSX2IP CKAP2 SKA3 CFAP53 NIN | 1.24e-05 | 770 | 110 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | centriole | 3.53e-05 | 172 | 110 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | microtubule | KIF21B CENPE KIF21A DNAH7 SPAG5 KIF15 CKAP2 SKA3 DNAH9 CFAP53 NIN | 1.17e-04 | 533 | 110 | 11 | GO:0005874 |
| GeneOntologyCellularComponent | cilium | GPI CCP110 ERC1 SPEF2 SDCCAG8 CEP290 PTPN23 DNAH7 SPAG5 CC2D2B SSX2IP DNAH9 CFAP53 NIN | 2.62e-04 | 898 | 110 | 14 | GO:0005929 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM1 TPM2 TPM3 KIF21B CENPE KIF21A DNAH7 SPAG5 KIF15 CKAP2 SKA3 DNAH9 CFAP53 NIN | 2.65e-04 | 899 | 110 | 14 | GO:0099513 |
| GeneOntologyCellularComponent | striated muscle thin filament | 3.78e-04 | 27 | 110 | 3 | GO:0005865 | |
| GeneOntologyCellularComponent | Rb-E2F complex | 4.06e-04 | 6 | 110 | 2 | GO:0035189 | |
| GeneOntologyCellularComponent | supramolecular fiber | TPM1 TPM2 TPM3 KIF21B MYH1 CENPE SYNE1 KIF21A DNAH7 SPAG5 KIF15 CKAP2 SKA3 DNAH9 CFAP53 NIN | 4.41e-04 | 1179 | 110 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM1 TPM2 TPM3 KIF21B MYH1 CENPE SYNE1 KIF21A DNAH7 SPAG5 KIF15 CKAP2 SKA3 DNAH9 CFAP53 NIN | 4.75e-04 | 1187 | 110 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | centriolar satellite | 5.83e-04 | 128 | 110 | 5 | GO:0034451 | |
| GeneOntologyCellularComponent | ciliary basal body | 5.85e-04 | 195 | 110 | 6 | GO:0036064 | |
| GeneOntologyCellularComponent | myofilament | 6.29e-04 | 32 | 110 | 3 | GO:0036379 | |
| GeneOntologyCellularComponent | mitotic spindle | 6.86e-04 | 201 | 110 | 6 | GO:0072686 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 7.53e-04 | 8 | 110 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TTF2 ERCC4 C9orf78 SYNE1 TFDP3 TFDP1 TFDP2 MEN1 RTF1 SART1 SUDS3 NFYC AFF1 SUZ12 CDC5L TAF5 DDX21 | 8.43e-04 | 1377 | 110 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.63e-03 | 161 | 110 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | growth cone | 1.89e-03 | 245 | 110 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | kinesin complex | 2.19e-03 | 49 | 110 | 3 | GO:0005871 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.22e-03 | 253 | 110 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 2.40e-03 | 14 | 110 | 2 | GO:0099569 | |
| HumanPheno | Macrotia | ERCC4 CENPE SYNE1 PCLO SDCCAG8 CEP290 PACS1 NALCN SUZ12 AP3D1 | 1.49e-05 | 271 | 37 | 10 | HP:0000400 |
| MousePheno | absent kidney epithelial cell primary cilium | 3.65e-05 | 2 | 85 | 2 | MP:0020384 | |
| MousePheno | thyroid gland cyst | 3.65e-05 | 2 | 85 | 2 | MP:0013528 | |
| Domain | Transc_factor_DP_C | 1.78e-07 | 3 | 106 | 3 | IPR014889 | |
| Domain | DP | 1.78e-07 | 3 | 106 | 3 | PF08781 | |
| Domain | DP | 1.78e-07 | 3 | 106 | 3 | SM01138 | |
| Domain | Transcrpt_fac_DP | 1.78e-07 | 3 | 106 | 3 | IPR015648 | |
| Domain | TROPOMYOSIN | 7.08e-07 | 4 | 106 | 3 | PS00326 | |
| Domain | Tropomyosin | 7.08e-07 | 4 | 106 | 3 | IPR000533 | |
| Domain | Tropomyosin | 7.08e-07 | 4 | 106 | 3 | PF00261 | |
| Domain | E2F_TDP | 2.84e-05 | 11 | 106 | 3 | PF02319 | |
| Domain | E2F_TDP | 2.84e-05 | 11 | 106 | 3 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 2.84e-05 | 11 | 106 | 3 | IPR003316 | |
| Domain | Kinesin-like_fam | 1.02e-04 | 43 | 106 | 4 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.12e-04 | 44 | 106 | 4 | PS00411 | |
| Domain | - | 1.12e-04 | 44 | 106 | 4 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.12e-04 | 44 | 106 | 4 | IPR001752 | |
| Domain | Kinesin | 1.12e-04 | 44 | 106 | 4 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.12e-04 | 44 | 106 | 4 | PS50067 | |
| Domain | KISc | 1.12e-04 | 44 | 106 | 4 | SM00129 | |
| Domain | Spectrin | 2.90e-04 | 23 | 106 | 3 | PF00435 | |
| Domain | P-loop_NTPase | KIF21B TTF2 MYH1 CENPE SPEF2 KIF21A SLFN14 DNAH7 SAMD9L KIF15 DDX21 DDX24 DHX29 DNAH9 | 3.09e-04 | 848 | 106 | 14 | IPR027417 |
| Domain | Spectrin_repeat | 5.83e-04 | 29 | 106 | 3 | IPR002017 | |
| Domain | Myb_DNA-binding | 1.02e-03 | 35 | 106 | 3 | PF00249 | |
| Domain | HTH_MYB | 1.12e-03 | 9 | 106 | 2 | PS51294 | |
| Domain | Myb_dom | 1.12e-03 | 9 | 106 | 2 | IPR017930 | |
| Domain | MYB_LIKE | 1.30e-03 | 38 | 106 | 3 | PS50090 | |
| Domain | - | 1.39e-03 | 10 | 106 | 2 | 1.10.220.60 | |
| Domain | Kinesin_motor_CS | 1.62e-03 | 41 | 106 | 3 | IPR019821 | |
| Domain | Grip | 1.70e-03 | 11 | 106 | 2 | SM00755 | |
| Domain | GRIP | 1.70e-03 | 11 | 106 | 2 | PF01465 | |
| Domain | GRIP_dom | 2.03e-03 | 12 | 106 | 2 | IPR000237 | |
| Domain | GRIP | 2.03e-03 | 12 | 106 | 2 | PS50913 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.78e-03 | 14 | 106 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.78e-03 | 14 | 106 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.78e-03 | 14 | 106 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.78e-03 | 14 | 106 | 2 | PF08393 | |
| Domain | MT | 2.78e-03 | 14 | 106 | 2 | PF12777 | |
| Domain | AAA_8 | 2.78e-03 | 14 | 106 | 2 | PF12780 | |
| Domain | SANT | 2.87e-03 | 50 | 106 | 3 | SM00717 | |
| Domain | DHC_fam | 3.19e-03 | 15 | 106 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 3.19e-03 | 15 | 106 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 3.19e-03 | 15 | 106 | 2 | PF03028 | |
| Domain | SANT/Myb | 3.21e-03 | 52 | 106 | 3 | IPR001005 | |
| Domain | Helicase_C | 3.23e-03 | 107 | 106 | 4 | PF00271 | |
| Domain | HELICc | 3.23e-03 | 107 | 106 | 4 | SM00490 | |
| Domain | Helicase_C | 3.34e-03 | 108 | 106 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 3.45e-03 | 109 | 106 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.45e-03 | 109 | 106 | 4 | PS51192 | |
| Domain | DEXDc | 3.45e-03 | 109 | 106 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 3.57e-03 | 110 | 106 | 4 | IPR014001 | |
| Domain | Synaptotagmin | 5.67e-03 | 20 | 106 | 2 | IPR001565 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 4.47e-06 | 41 | 85 | 5 | MM14876 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.34e-05 | 51 | 85 | 5 | M665 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 5.59e-05 | 35 | 85 | 4 | MM15114 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.95e-05 | 77 | 85 | 5 | MM14670 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.27e-04 | 43 | 85 | 4 | M1429 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 1.42e-04 | 189 | 85 | 7 | MM15356 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.21e-04 | 203 | 85 | 7 | M27654 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.55e-04 | 94 | 85 | 5 | M1041 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.10e-04 | 98 | 85 | 5 | MM15352 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.40e-04 | 100 | 85 | 5 | M27650 | |
| Pathway | REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 3.55e-04 | 5 | 85 | 2 | M26903 | |
| Pathway | REACTOME_KINESINS | 3.81e-04 | 57 | 85 | 4 | MM15714 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 4.42e-04 | 25 | 85 | 3 | MM15546 | |
| Pathway | REACTOME_KINESINS | 4.95e-04 | 61 | 85 | 4 | M977 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 4.98e-04 | 26 | 85 | 3 | MM14878 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 7.26e-04 | 118 | 85 | 5 | MM15588 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6 | 1.11e-03 | 34 | 85 | 3 | M27826 | |
| Pathway | WP_JOUBERT_SYNDROME | 1.14e-03 | 76 | 85 | 4 | M39835 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.16e-03 | 131 | 85 | 5 | MM15497 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.20e-03 | 35 | 85 | 3 | MM15005 | |
| Pathway | BIOCARTA_FBW7_PATHWAY | 1.26e-03 | 9 | 85 | 2 | MM1568 | |
| Pathway | REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.26e-03 | 9 | 85 | 2 | M26946 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 1.29e-03 | 134 | 85 | 5 | M27751 | |
| Pathway | REACTOME_STRIATED_MUSCLE_CONTRACTION | 1.31e-03 | 36 | 85 | 3 | M18647 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.31e-03 | 36 | 85 | 3 | M633 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.34e-03 | 201 | 85 | 6 | MM15411 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.42e-03 | 37 | 85 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.42e-03 | 37 | 85 | 3 | MM15610 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 1.53e-03 | 38 | 85 | 3 | M39549 | |
| Pathway | BIOCARTA_SKP2E2F_PATHWAY | 1.57e-03 | 10 | 85 | 2 | MM1384 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | CYBB TPM3 CCP110 CENPE TIAM2 MEN1 ARFGAP3 MACO1 WASF2 PAK2 TAOK1 | 1.74e-03 | 649 | 85 | 11 | MM15690 |
| Pathway | REACTOME_MRNA_SPLICING | 1.76e-03 | 212 | 85 | 6 | M14033 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM3 GPI TTF2 ERC1 RBM26 PTPN23 SPAG5 PARP1 PA2G4 WASF2 PAK2 CKAP2 CDC5L SKA3 DDX21 DHX29 UTRN TOP1 AP3D1 TOP2B | 3.28e-11 | 934 | 115 | 20 | 33916271 |
| Pubmed | TPM1 SCRN3 ERCC4 RPS6KA3 PTPN23 SPATA1 TIAM2 SPAG5 MEN1 PACS1 FAM32A PA2G4 CSNK1G3 NFYC SYT1 AFF1 TAOK1 CKAP2 DDX21 UTRN BICC1 | 6.31e-11 | 1084 | 115 | 21 | 11544199 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM3 GPI WBP11 ERC1 C9orf78 KIF21A RBM26 PTPN23 SPAG5 LRRC47 MSN RTF1 SART1 PARP1 PA2G4 WASF2 CDC5L DDX21 DDX24 TOP1 AP3D1 GOLGA4 TOP2B | 2.19e-10 | 1415 | 115 | 23 | 28515276 |
| Pubmed | TPM1 TPM2 TPM3 MYH1 WBP11 ERC1 SYNE1 SPEF2 KIF21A PCLO PPP1R9A CCDC150 LLPH CXorf65 MEN1 MSN SART1 PARP1 EEA1 DDX21 TOP1 AP3D1 TOP2B | 3.17e-10 | 1442 | 115 | 23 | 35575683 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM1 TPM2 TPM3 GPI KIF21B TTF2 ERC1 KIF21A MSN SART1 PARP1 PA2G4 EEA1 DDX21 DHX29 UTRN TOP1 AP3D1 | 3.95e-10 | 847 | 115 | 18 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TPM3 TTF2 CENPE DIS3L CEP85L ERC1 SDCCAG8 CEP290 PTPN23 DNAH7 SPAG5 MEN1 ARFGAP3 MACO1 WASF2 SSX2IP CKAP2 NIN | 4.42e-10 | 853 | 115 | 18 | 28718761 |
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 3.00e-09 | 18 | 115 | 5 | 11149944 | |
| Pubmed | 6.31e-09 | 234 | 115 | 10 | 36243803 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | TTF2 CEP290 LLPH SKIL TTF1 MEN1 NCBP2 SART1 PARP1 SUDS3 MACO1 PDCD11 SUZ12 CKAP2 CDC5L TAF5 DDX21 DDX24 TOP1 TOP2B | 9.02e-09 | 1294 | 115 | 20 | 30804502 |
| Pubmed | RPS6KA3 SLFN14 TFDP1 MSN PARP1 PA2G4 PAK2 SUZ12 SKA3 DDX21 UTRN AP3D1 | 1.30e-08 | 411 | 115 | 12 | 36652389 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPM3 GPI TTF2 KIF21A PTPN23 LRRC47 MSN SART1 PARP1 PA2G4 PDCD11 CDC5L DDX21 DDX24 DHX29 UTRN TOP1 AP3D1 GOLGA4 TOP2B | 1.89e-08 | 1353 | 115 | 20 | 29467282 |
| Pubmed | KIF21B WBP11 CENPE ERC1 SYNE1 KIF21A PPP1R9A MSN SART1 PARP1 KIF15 WASF2 PAK2 SYT1 CDC5L TAF5 GOLGA4 | 1.97e-08 | 963 | 115 | 17 | 28671696 | |
| Pubmed | TPM1 TPM2 TPM3 GPI WBP11 RPS6KA3 RBM26 LLPH TTF1 LRRC47 NCBP2 PARP1 FAM32A PA2G4 PDCD11 TAOK1 EEA1 DDX21 TOP1 AP3D1 | 2.35e-08 | 1371 | 115 | 20 | 36244648 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPM1 TPM2 TTF2 RBM26 SKIL TTF1 TFDP1 MEN1 SART1 SUDS3 PA2G4 WASF2 NFYC DDX21 DDX24 TOP2B | 2.48e-08 | 857 | 115 | 16 | 25609649 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPE TRAIP TTF1 SART1 PA2G4 PDCD11 SUZ12 CKAP2 CDC5L DDX21 DDX24 DHX29 TOP1 AP3D1 TOP2B | 3.36e-08 | 759 | 115 | 15 | 35915203 |
| Pubmed | Vertebrate tropomyosin: distribution, properties and function. | 3.52e-08 | 3 | 115 | 3 | 11563548 | |
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 15282318 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 7568216 | ||
| Pubmed | 3.52e-08 | 3 | 115 | 3 | 9000141 | ||
| Pubmed | 5.63e-08 | 295 | 115 | 10 | 26209609 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RBM26 SART1 PARP1 PDCD11 SUZ12 EEA1 CDC5L TAF5 DDX21 DDX24 UTRN | 8.52e-08 | 394 | 115 | 11 | 27248496 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | TPM1 GPI WBP11 SYNE1 MSN SART1 PARP1 PA2G4 CDC5L DDX21 DDX24 TOP1 AP3D1 TOP2B | 1.10e-07 | 714 | 115 | 14 | 28302793 |
| Pubmed | Ca2+-dependent interaction of S100A2 with muscle and nonmuscle tropomyosins. | 1.41e-07 | 4 | 115 | 3 | 9092943 | |
| Pubmed | A systematic nomenclature for mammalian tropomyosin isoforms. | 1.41e-07 | 4 | 115 | 3 | 25369766 | |
| Pubmed | Degradation of cytoskeletal proteins by the human immunodeficiency virus type 1 protease. | 1.41e-07 | 4 | 115 | 3 | 1516138 | |
| Pubmed | 1.41e-07 | 4 | 115 | 3 | 9108196 | ||
| Pubmed | Tropomyosin isoforms localize to distinct microfilament populations in osteoclasts. | 1.41e-07 | 4 | 115 | 3 | 16765662 | |
| Pubmed | 2.00e-07 | 16 | 115 | 4 | 16494860 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPM3 GPI SYNE1 PCLO RBM26 LRRC47 SART1 PARP1 PA2G4 PDCD11 SUZ12 EEA1 CDC5L DDX21 DDX24 DHX29 TOP1 GOLGA4 TOP2B | 2.21e-07 | 1425 | 115 | 19 | 30948266 |
| Pubmed | CCP110 ERC1 C9orf78 CEP290 SPAG5 MEN1 LRRC47 SSX2IP SUZ12 CKAP2 SKA3 UTRN NIN | 2.36e-07 | 645 | 115 | 13 | 25281560 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPM3 GPI WBP11 SYNE1 PPP1R9A CEP290 SART1 PARP1 PA2G4 PDCD11 EEA1 CDC5L DDX21 UTRN TOP1 TOP2B | 2.78e-07 | 1024 | 115 | 16 | 24711643 |
| Pubmed | KIF21B WBP11 MEN1 MSN SART1 PARP1 PA2G4 CSNK1G3 NFYC CDC5L DDX21 TOP1 TOP2B | 3.06e-07 | 660 | 115 | 13 | 32780723 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPI CCP110 WBP11 GOLGA6L2 ERC1 SDCCAG8 CEP290 CCDC150 CCDC122 SPAG5 LRRC47 SART1 PACS1 PA2G4 ARFGAP3 GCC2 EEA1 DDX24 | 3.50e-07 | 1321 | 115 | 18 | 27173435 |
| Pubmed | 3.55e-07 | 360 | 115 | 10 | 33111431 | ||
| Pubmed | TPM1 TPM3 SYNE1 PPP1R9A RBM26 LLPH TTF1 MEN1 NCBP2 PA2G4 ARFGAP3 MACO1 WASF2 PDCD11 SUZ12 CKAP2 TAF5 DHX29 UTRN | 4.68e-07 | 1497 | 115 | 19 | 31527615 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | WBP11 SYNE1 RBM26 LLPH LRRC47 NCBP2 SART1 PARP1 PDCD11 CDC5L DDX21 DDX24 DHX29 TOP1 | 4.80e-07 | 807 | 115 | 14 | 22681889 |
| Pubmed | 5.26e-07 | 210 | 115 | 8 | 16565220 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CCP110 CDKL2 ERC1 RPS6KA3 LLPH MSN RTF1 SART1 SUDS3 PDCD11 AFF1 DDX21 TOP1 | 5.47e-07 | 695 | 115 | 13 | 23602568 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM1 TPM2 TPM3 SYNE1 PPP1R9A LLPH LRRC47 MSN SART1 PARP1 PDCD11 CDC5L DDX21 TOP1 AP3D1 | 5.87e-07 | 949 | 115 | 15 | 36574265 |
| Pubmed | Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes. | 6.99e-07 | 6 | 115 | 3 | 20176812 | |
| Pubmed | 6.99e-07 | 6 | 115 | 3 | 23792823 | ||
| Pubmed | TPM1 TPM2 TPM3 LRRC47 MSN SART1 TAOK1 EEA1 DDX21 TOP1 AP3D1 TOP2B | 7.78e-07 | 601 | 115 | 12 | 33658012 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 8.31e-07 | 52 | 115 | 5 | 24591637 | |
| Pubmed | 1.06e-06 | 159 | 115 | 7 | 22751105 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 1.12e-06 | 101 | 115 | 6 | 24613305 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.20e-06 | 162 | 115 | 7 | 31363146 | |
| Pubmed | 1.22e-06 | 7 | 115 | 3 | 12588846 | ||
| Pubmed | GPI WBP11 RBM26 MSN RTF1 NCBP2 SART1 PARP1 SUDS3 PA2G4 PAK2 SUZ12 CDC5L TOP1 TOP2B | 1.34e-06 | 1014 | 115 | 15 | 32416067 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | TPM3 RPS6KA3 LLPH TTF1 NCBP2 PARP1 PA2G4 PAK2 PDCD11 TAOK1 CDC5L TAF5 DDX21 DDX24 TOP1 AP3D1 TOP2B | 1.62e-06 | 1318 | 115 | 17 | 30463901 |
| Pubmed | WBP11 SYNE1 TFDP1 LRRC47 PARP1 PA2G4 MACO1 SSX2IP PDCD11 CKAP2 CDC5L DDX21 DDX24 DHX29 AP3D1 GOLGA4 TOP2B NIN | 1.90e-06 | 1487 | 115 | 18 | 33957083 | |
| Pubmed | WBP11 ERC1 PPP1R9A CEP290 PTPN23 PACS1 PARP1 KIF15 MACO1 SSX2IP CKAP2 CDC5L UTRN GOLGA4 NIN | 2.03e-06 | 1049 | 115 | 15 | 27880917 | |
| Pubmed | 2.03e-06 | 339 | 115 | 9 | 30415952 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.39e-06 | 361 | 115 | 9 | 26167880 | |
| Pubmed | TTF2 RBM26 LRRC47 NCBP2 SART1 PARP1 PA2G4 PDCD11 CKAP2 CDC5L DDX21 DDX24 DHX29 TOP1 | 4.16e-06 | 971 | 115 | 14 | 33306668 | |
| Pubmed | TPM1 TPM3 WBP11 ERCC4 DIS3L LLPH TFDP1 TFDP2 MSN FHAD1 SUDS3 NFYC PDCD11 TAF5 DDX24 TOP1 FILIP1L | 4.77e-06 | 1429 | 115 | 17 | 35140242 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 CCDC73 CENPE CDKL2 KIF21A PCLO CEP290 FAM227B LRRC47 SAMD9L UTRN BANK1 | 6.23e-06 | 736 | 115 | 12 | 29676528 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPM1 GPI CENPE C9orf78 SYNE1 LLPH SPAG5 SART1 PACS1 PA2G4 EEA1 CDC5L DDX21 TOP2B MYBL1 | 6.48e-06 | 1155 | 115 | 15 | 20360068 |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 6.89e-06 | 37 | 115 | 4 | 11416179 | |
| Pubmed | 7.04e-06 | 503 | 115 | 10 | 16964243 | ||
| Pubmed | 7.14e-06 | 396 | 115 | 9 | 26687479 | ||
| Pubmed | 7.58e-06 | 12 | 115 | 3 | 8424456 | ||
| Pubmed | 9.53e-06 | 146 | 115 | 6 | 21399614 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPM3 C9orf78 SART1 PACS1 AFF1 TAOK1 SUZ12 DDX21 DDX24 DHX29 GOLGA4 TOP2B | 1.03e-05 | 774 | 115 | 12 | 15302935 |
| Pubmed | Isolation and characterization of a cDNA that encodes mouse fibroblast tropomyosin isoform 2. | 1.08e-05 | 2 | 115 | 2 | 3244365 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 30545627 | ||
| Pubmed | High molecular weight tropomyosins regulate osteoclast cytoskeletal morphology. | 1.08e-05 | 2 | 115 | 2 | 18674650 | |
| Pubmed | Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II. | 1.08e-05 | 2 | 115 | 2 | 15680922 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 10225949 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8446173 | ||
| Pubmed | Interaction of DNA topoisomerase 1 with DNA intermediates and proteins of base excision repair. | 1.08e-05 | 2 | 115 | 2 | 19916945 | |
| Pubmed | Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells. | 1.08e-05 | 2 | 115 | 2 | 20875401 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22798622 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 1316530 | ||
| Pubmed | Changes in end-to-end interactions of tropomyosin affect mouse cardiac muscle dynamics. | 1.08e-05 | 2 | 115 | 2 | 16501024 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14633688 | ||
| Pubmed | Variants in tropomyosins TPM2 and TPM3 causing muscle hypertonia. | 1.08e-05 | 2 | 115 | 2 | 38219297 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22740512 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24507666 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 26391493 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8760295 | ||
| Pubmed | Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. | 1.08e-05 | 2 | 115 | 2 | 17416600 | |
| Pubmed | Renaturation of skeletal muscle tropomyosin: implications for in vivo assembly. | 1.08e-05 | 2 | 115 | 2 | 3857586 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9161421 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 25815590 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 9139687 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22158865 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24692096 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 31351877 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 1796905 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 17383637 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23205574 | ||
| Pubmed | Regulation of Actin Filament Length by Muscle Isoforms of Tropomyosin and Cofilin. | 1.08e-05 | 2 | 115 | 2 | 32560136 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 24013388 | ||
| Pubmed | Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. | 1.08e-05 | 2 | 115 | 2 | 7684495 | |
| Pubmed | A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes. | 1.08e-05 | 2 | 115 | 2 | 18515798 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 34903139 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 8413592 | ||
| Pubmed | Specific features of neuronal size and shape are regulated by tropomyosin isoforms. | 1.08e-05 | 2 | 115 | 2 | 15888546 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15247263 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 22550344 | ||
| Interaction | NDC80 interactions | CCP110 CENPE CEP85L ERC1 CEP290 SPAG5 SART1 KIF15 GCC2 SSX2IP PDCD11 CDC5L SKA3 TOP1 NIN | 2.99e-10 | 312 | 115 | 15 | int:NDC80 |
| Interaction | PCM1 interactions | CCP110 TTF2 CENPE CDKL2 CEP85L ERC1 CEP290 SPAG5 KIF15 GCC2 SSX2IP CKAP2 EEA1 CCDC183 NIN | 2.62e-08 | 434 | 115 | 15 | int:PCM1 |
| Interaction | CFAP184 interactions | 3.08e-08 | 162 | 115 | 10 | int:CFAP184 | |
| Interaction | MAGEA9 interactions | 3.21e-07 | 208 | 115 | 10 | int:MAGEA9 | |
| Interaction | THOC1 interactions | 3.51e-07 | 210 | 115 | 10 | int:THOC1 | |
| Interaction | DDX23 interactions | WBP11 C9orf78 SYNE1 RBM26 MEN1 RTF1 SART1 PDCD11 SUZ12 CDC5L DDX21 DDX24 TOP1 TOP2B | 6.20e-07 | 480 | 115 | 14 | int:DDX23 |
| Interaction | NAA40 interactions | TPM3 GPI TTF2 ERC1 RBM26 PTPN23 SPAG5 PARP1 PA2G4 WASF2 PAK2 CKAP2 CDC5L SKA3 DDX21 DHX29 UTRN TOP1 AP3D1 TOP2B | 6.29e-07 | 978 | 115 | 20 | int:NAA40 |
| Interaction | SRPK2 interactions | WBP11 ERC1 RBM26 LLPH MEN1 RTF1 NCBP2 SART1 GCC2 MACO1 PDCD11 CDC5L DDX21 DDX24 DNAH9 TOP1 TOP2B | 6.53e-07 | 717 | 115 | 17 | int:SRPK2 |
| Interaction | SYCE1 interactions | 6.70e-07 | 127 | 115 | 8 | int:SYCE1 | |
| Interaction | CCHCR1 interactions | TPM1 TPM3 SPAG5 SSX2IP CCDC102B CCDC183 CFAP53 DEUP1 CCDC33 NIN | 7.76e-07 | 229 | 115 | 10 | int:CCHCR1 |
| Interaction | NIN interactions | TTF2 CENPE CEP85L ERC1 CEP290 SPAG5 MEN1 SSX2IP CKAP2 SKA3 AP3D1 NIN | 1.01e-06 | 359 | 115 | 12 | int:NIN |
| Interaction | MFAP1 interactions | MEN1 SART1 PARP1 SSX2IP FAM76A AFF1 SUZ12 CCDC102B TOP1 TOP2B CCDC33 | 1.01e-06 | 295 | 115 | 11 | int:MFAP1 |
| Interaction | POU5F1 interactions | TTF2 ERC1 LRRC47 CC2D2B PARP1 SUDS3 NFYC TAOK1 SUZ12 CDC5L DDX24 DHX29 TOP1 AP3D1 TOP2B | 1.18e-06 | 584 | 115 | 15 | int:POU5F1 |
| Interaction | PCNT interactions | CEP85L SYNE1 CEP290 SSX2IP SUZ12 CDC5L CCDC183 UTRN DEUP1 NIN | 1.23e-06 | 241 | 115 | 10 | int:PCNT |
| Interaction | SEPTIN10 interactions | 1.74e-06 | 144 | 115 | 8 | int:SEPTIN10 | |
| Interaction | EFTUD2 interactions | TPM3 GPI WBP11 ERC1 C9orf78 KIF21A RBM26 SPAG5 MEN1 LRRC47 MSN RTF1 SART1 PARP1 PA2G4 WASF2 SUZ12 CDC5L DDX21 DDX24 TOP1 AP3D1 GOLGA4 TOP2B | 1.81e-06 | 1449 | 115 | 24 | int:EFTUD2 |
| Interaction | HECTD1 interactions | TPM2 CENPE TRAIP TTF1 SART1 PARP1 PA2G4 PDCD11 SUZ12 CKAP2 CDC5L DDX21 DDX24 DHX29 UTRN TOP1 AP3D1 TOP2B NIN | 2.90e-06 | 984 | 115 | 19 | int:HECTD1 |
| Interaction | LIN9 interactions | 3.41e-06 | 111 | 115 | 7 | int:LIN9 | |
| Interaction | SASS6 interactions | 3.64e-06 | 159 | 115 | 8 | int:SASS6 | |
| Interaction | SCARNA22 interactions | 5.13e-06 | 118 | 115 | 7 | int:SCARNA22 | |
| Interaction | MAPRE3 interactions | 6.92e-06 | 230 | 115 | 9 | int:MAPRE3 | |
| Interaction | YWHAG interactions | TPM1 TPM3 KIF21B CCP110 CEP85L ERC1 RPS6KA3 DNAH7 PACS1 KIF15 CSNK1G3 GCC2 WASF2 SSX2IP PAK2 TAOK1 CKAP2 CDC5L SKA3 UTRN BICC1 | 7.03e-06 | 1248 | 115 | 21 | int:YWHAG |
| Interaction | CEP128 interactions | CCP110 TTF2 CEP85L ERC1 CEP290 LRRC47 ARFGAP3 SSX2IP DEUP1 NIN | 7.92e-06 | 297 | 115 | 10 | int:CEP128 |
| Interaction | ANAPC2 interactions | 7.95e-06 | 234 | 115 | 9 | int:ANAPC2 | |
| Interaction | CCDC14 interactions | 9.23e-06 | 129 | 115 | 7 | int:CCDC14 | |
| Interaction | CEP104 interactions | 1.20e-05 | 89 | 115 | 6 | int:CEP104 | |
| Interaction | HDAC1 interactions | TPM1 MYH1 ERC1 C9orf78 SKIL TFDP1 SPAG5 MEN1 PARP1 KIF15 SUDS3 GCC2 NFYC AFF1 SUZ12 SKA3 UTRN GOLGA4 TOP2B | 1.58e-05 | 1108 | 115 | 19 | int:HDAC1 |
| Interaction | SMC2 interactions | CCP110 CENPE C9orf78 MEN1 MSN SART1 PARP1 SUZ12 CDC5L GOLGA4 | 1.64e-05 | 323 | 115 | 10 | int:SMC2 |
| Interaction | MTREX interactions | 1.96e-05 | 262 | 115 | 9 | int:MTREX | |
| Interaction | USP39 interactions | 2.02e-05 | 201 | 115 | 8 | int:USP39 | |
| Interaction | KRT18 interactions | CCP110 ERC1 RPS6KA3 CEP290 SPAG5 KIF15 MACO1 SSX2IP PAK2 CDC5L NIN | 2.82e-05 | 419 | 115 | 11 | int:KRT18 |
| Interaction | MAGEB5 interactions | 3.23e-05 | 2 | 115 | 2 | int:MAGEB5 | |
| Interaction | DISC1 interactions | TPM2 TPM3 SYNE1 CEP290 CCDC141 TIAM2 SPAG5 CDC5L CCDC102B UTRN TOP1 | 3.50e-05 | 429 | 115 | 11 | int:DISC1 |
| Interaction | CDK9 interactions | TPM1 TPM2 TPM3 MEN1 MSN SART1 PARP1 MROH7 PDCD11 AFF1 CDC5L DDX21 DDX24 TOP1 | 3.60e-05 | 685 | 115 | 14 | int:CDK9 |
| Interaction | TFPT interactions | 3.73e-05 | 160 | 115 | 7 | int:TFPT | |
| Interaction | MAPRE1 interactions | CENPE ERC1 CEP290 SPAG5 PA2G4 GCC2 SSX2IP SUZ12 CKAP2 SKA3 DDX21 NIN | 3.80e-05 | 514 | 115 | 12 | int:MAPRE1 |
| Interaction | TMOD1 interactions | 3.88e-05 | 161 | 115 | 7 | int:TMOD1 | |
| Interaction | ADAR interactions | 3.89e-05 | 286 | 115 | 9 | int:ADAR | |
| Interaction | TOP1 interactions | TRAIP MEN1 NCBP2 SART1 PARP1 PA2G4 NFYC SUZ12 CDC5L DDX21 DDX24 DHX29 TOP1 TOP2B | 4.28e-05 | 696 | 115 | 14 | int:TOP1 |
| Interaction | PRPF3 interactions | 4.45e-05 | 291 | 115 | 9 | int:PRPF3 | |
| Interaction | RHOBTB2 interactions | 4.53e-05 | 165 | 115 | 7 | int:RHOBTB2 | |
| Interaction | PGK1 interactions | 4.86e-05 | 367 | 115 | 10 | int:PGK1 | |
| Interaction | RBM28 interactions | 4.97e-05 | 368 | 115 | 10 | int:RBM28 | |
| Interaction | PRPF40A interactions | WBP11 SPATA1 MEN1 SART1 PARP1 WASF2 FAM76A CDC5L SKA3 DDX21 TOP1 | 4.97e-05 | 446 | 115 | 11 | int:PRPF40A |
| Interaction | CEP162 interactions | 5.08e-05 | 168 | 115 | 7 | int:CEP162 | |
| Interaction | SNAPIN interactions | 5.28e-05 | 169 | 115 | 7 | int:SNAPIN | |
| Interaction | OBSL1 interactions | TPM3 GPI WBP11 SYNE1 PCLO SART1 PARP1 PA2G4 PDCD11 SUZ12 CDC5L DDX21 DHX29 UTRN TOP1 TOP2B | 5.34e-05 | 902 | 115 | 16 | int:OBSL1 |
| Interaction | MED4 interactions | KIF21B CCP110 CENPE ERC1 CEP290 SPAG5 LRRC47 SSX2IP SKA3 UTRN NIN | 5.39e-05 | 450 | 115 | 11 | int:MED4 |
| Interaction | KXD1 interactions | 5.48e-05 | 170 | 115 | 7 | int:KXD1 | |
| Interaction | IFI16 interactions | SYNE1 PPP1R9A LLPH IFIT2 MEN1 SART1 PARP1 PDCD11 CDC5L DDX21 DDX24 DHX29 TOP1 TOP2B | 5.64e-05 | 714 | 115 | 14 | int:IFI16 |
| Interaction | TNIP1 interactions | TPM1 TPM2 TPM3 TTF2 SYNE1 PPP1R9A PTPN23 LLPH LRRC47 MSN SART1 PARP1 SSX2IP PDCD11 CDC5L DDX21 CFAP53 TOP1 AP3D1 | 5.69e-05 | 1217 | 115 | 19 | int:TNIP1 |
| Interaction | DDX56 interactions | 6.24e-05 | 304 | 115 | 9 | int:DDX56 | |
| Interaction | CRNKL1 interactions | 7.07e-05 | 177 | 115 | 7 | int:CRNKL1 | |
| Interaction | STOX1 interactions | 7.83e-05 | 15 | 115 | 3 | int:STOX1 | |
| Interaction | SUZ12 interactions | CCP110 C9orf78 SYNE1 CEP290 CCDC141 NCBP2 SART1 PARP1 SUDS3 PDCD11 SUZ12 CDC5L TOP1 | 7.90e-05 | 644 | 115 | 13 | int:SUZ12 |
| Interaction | PDS5A interactions | 8.22e-05 | 245 | 115 | 8 | int:PDS5A | |
| Interaction | SREK1 interactions | 8.71e-05 | 183 | 115 | 7 | int:SREK1 | |
| Interaction | CAPZB interactions | TPM1 TPM2 TPM3 GPI ERC1 PPP1R9A MSN PARP1 ARFGAP3 NFYC EEA1 CDC5L DDX24 DHX29 TOP2B CCDC33 NIN | 9.32e-05 | 1049 | 115 | 17 | int:CAPZB |
| Interaction | BICD1 interactions | 9.46e-05 | 250 | 115 | 8 | int:BICD1 | |
| Interaction | FOXP1 interactions | 1.12e-04 | 256 | 115 | 8 | int:FOXP1 | |
| Interaction | POLR1G interactions | WBP11 C9orf78 TTF1 MEN1 RTF1 FAM32A PDCD11 DDX21 DDX24 TOP1 TOP2B | 1.13e-04 | 489 | 115 | 11 | int:POLR1G |
| Interaction | SPICE1 interactions | 1.14e-04 | 191 | 115 | 7 | int:SPICE1 | |
| Interaction | PRP4K interactions | 1.14e-04 | 329 | 115 | 9 | int:PRP4K | |
| Interaction | CNTRL interactions | 1.21e-04 | 193 | 115 | 7 | int:CNTRL | |
| Interaction | CDCA7L interactions | 1.26e-04 | 85 | 115 | 5 | int:CDCA7L | |
| Interaction | RPS6 interactions | PCLO LLPH TTF1 CXorf65 MEN1 RTF1 PA2G4 PAK2 PDCD11 CDC5L DDX21 DDX24 DHX29 TOP1 TOP2B | 1.34e-04 | 874 | 115 | 15 | int:RPS6 |
| Interaction | NUPR1 interactions | KIF21B WBP11 MEN1 MSN SART1 PARP1 PA2G4 CSNK1G3 NFYC CDC5L DDX21 TOP1 TOP2B | 1.42e-04 | 683 | 115 | 13 | int:NUPR1 |
| Interaction | VPS33B interactions | 1.47e-04 | 199 | 115 | 7 | int:VPS33B | |
| Interaction | SNRNP70 interactions | TPM3 DIS3L RBM26 SKIL IFIT2 MEN1 NCBP2 SART1 SUZ12 CDC5L SKA3 DDX21 DDX24 DHX29 TOP1 TOP2B | 1.47e-04 | 984 | 115 | 16 | int:SNRNP70 |
| Interaction | IMPDH2 interactions | 1.48e-04 | 420 | 115 | 10 | int:IMPDH2 | |
| Interaction | CDK2 interactions | TPM1 TPM2 TPM3 GPI CCP110 TFDP1 TFDP2 MSN PARP1 PA2G4 NFYC CDC5L DDX21 TOP1 | 1.49e-04 | 783 | 115 | 14 | int:CDK2 |
| Interaction | YWHAH interactions | KIF21B CCP110 CEP85L ERC1 RPS6KA3 CEP290 DNAH7 PACS1 WASF2 SSX2IP PAK2 TAOK1 SKA3 UTRN BICC1 GOLGA4 NIN | 1.69e-04 | 1102 | 115 | 17 | int:YWHAH |
| Interaction | OFD1 interactions | 1.70e-04 | 347 | 115 | 9 | int:OFD1 | |
| Interaction | ANOS1 interactions | 1.71e-04 | 143 | 115 | 6 | int:ANOS1 | |
| Interaction | CBX4 interactions | 1.76e-04 | 205 | 115 | 7 | int:CBX4 | |
| Interaction | TRIM36 interactions | 1.78e-04 | 144 | 115 | 6 | int:TRIM36 | |
| Interaction | RFC5 interactions | 1.82e-04 | 206 | 115 | 7 | int:RFC5 | |
| Interaction | NCL interactions | RPS6KA3 TRAIP SART1 PARP1 PA2G4 PDCD11 SYT1 SUZ12 CDC5L DDX21 DDX24 TOP1 TOP2B MYBL1 | 1.82e-04 | 798 | 115 | 14 | int:NCL |
| Interaction | H3C1 interactions | TPM1 WBP11 C9orf78 SYNE1 RPS6KA3 CEP290 MEN1 PARP1 GCC2 SUZ12 TAF5 DDX24 DNAH9 TOP1 TOP2B | 1.87e-04 | 901 | 115 | 15 | int:H3C1 |
| Interaction | RRAD interactions | 1.92e-04 | 20 | 115 | 3 | int:RRAD | |
| Interaction | LIN37 interactions | 1.93e-04 | 93 | 115 | 5 | int:LIN37 | |
| Interaction | GEM interactions | 1.99e-04 | 147 | 115 | 6 | int:GEM | |
| Interaction | MCM3 interactions | 2.01e-04 | 355 | 115 | 9 | int:MCM3 | |
| Interaction | DCTN2 interactions | 2.06e-04 | 356 | 115 | 9 | int:DCTN2 | |
| Interaction | MACROH2A2 interactions | 2.10e-04 | 211 | 115 | 7 | int:MACROH2A2 | |
| Interaction | SMC4 interactions | 2.11e-04 | 281 | 115 | 8 | int:SMC4 | |
| Interaction | CPSF6 interactions | WBP11 RBM26 MEN1 NCBP2 SART1 PARP1 PA2G4 SUZ12 CDC5L TOP1 GOLGA4 | 2.13e-04 | 526 | 115 | 11 | int:CPSF6 |
| Interaction | KRT19 interactions | 2.16e-04 | 282 | 115 | 8 | int:KRT19 | |
| Interaction | GOLGA8F interactions | 2.23e-04 | 21 | 115 | 3 | int:GOLGA8F | |
| Interaction | ZNF330 interactions | 2.40e-04 | 446 | 115 | 10 | int:ZNF330 | |
| Interaction | RNF20 interactions | 2.43e-04 | 216 | 115 | 7 | int:RNF20 | |
| Interaction | SUMO1 interactions | 2.43e-04 | 287 | 115 | 8 | int:SUMO1 | |
| Interaction | HSPH1 interactions | TPM3 C9orf78 RPS6KA3 PTPN23 MSN RTF1 SART1 WASF2 UTRN GOLGA4 | 2.48e-04 | 448 | 115 | 10 | int:HSPH1 |
| Interaction | TNNI1 interactions | 2.55e-04 | 54 | 115 | 4 | int:TNNI1 | |
| Interaction | NDN interactions | 2.71e-04 | 453 | 115 | 10 | int:NDN | |
| Interaction | DHX8 interactions | 2.73e-04 | 292 | 115 | 8 | int:DHX8 | |
| Interaction | MYCN interactions | TPM1 TPM2 TPM3 WBP11 C9orf78 SYNE1 LLPH NCBP2 SART1 PARP1 FAM32A CSNK1G3 PDCD11 SUZ12 CKAP2 CDC5L DDX21 DDX24 TOP1 | 2.74e-04 | 1373 | 115 | 19 | int:MYCN |
| Interaction | NUP107 interactions | 2.79e-04 | 221 | 115 | 7 | int:NUP107 | |
| Interaction | RBM39 interactions | TPM1 GPI WBP11 SYNE1 MSN NCBP2 SART1 PARP1 PA2G4 SUZ12 CDC5L DDX21 DDX24 TOP1 AP3D1 TOP2B | 2.81e-04 | 1042 | 115 | 16 | int:RBM39 |
| Interaction | KIAA0753 interactions | 2.84e-04 | 157 | 115 | 6 | int:KIAA0753 | |
| GeneFamily | Transcription factor Dp family | 5.32e-08 | 3 | 69 | 3 | 987 | |
| GeneFamily | Tropomyosins | 2.12e-07 | 4 | 69 | 3 | 777 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.81e-05 | 46 | 69 | 4 | 622 | |
| GeneFamily | Topoisomerases | 2.13e-04 | 6 | 69 | 2 | 1050 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.09e-03 | 53 | 69 | 3 | 532 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.46e-03 | 15 | 69 | 2 | 26 | |
| GeneFamily | Dyneins, axonemal | 1.88e-03 | 17 | 69 | 2 | 536 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 2.88e-03 | 21 | 69 | 2 | 980 | |
| GeneFamily | Sterile alpha motif domain containing | 4.63e-03 | 88 | 69 | 3 | 760 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.06e-03 | 181 | 69 | 4 | 694 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.32e-03 | 36 | 69 | 2 | 823 | |
| GeneFamily | DEAD-box helicases | 1.12e-02 | 42 | 69 | 2 | 499 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CENPE CEP290 RBM26 LLPH KIF15 GCC2 SUZ12 EEA1 CDC5L DDX21 DHX29 GOLGA4 TOP2B MYBL1 NIN | 1.71e-07 | 656 | 114 | 15 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TPM3 KIF21B CEP85L C9orf78 SYNE1 SPEF2 RPS6KA3 RBM26 ITGAL MSN PACS1 PARP1 SAMD9L PAK2 TAOK1 SUZ12 CKAP2 DDX24 UTRN TOP2B MYBL1 NIN | 4.14e-07 | 1492 | 114 | 22 | M40023 |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | TPM3 KIF21B CEP85L C9orf78 SYNE1 RPS6KA3 RBM26 ITGAL MSN SAMD9L TAOK1 DDX21 DDX24 UTRN TOP2B MYBL1 NIN | 4.27e-07 | 911 | 114 | 17 | M40038 |
| Coexpression | FISCHER_DREAM_TARGETS | TTF2 WBP11 CENPE TRAIP CCDC150 TTF1 TFDP1 SPAG5 KIF15 EBAG9 SUZ12 CKAP2 TAF5 SKA3 DDX21 TOP1 MYBL1 | 1.00e-06 | 969 | 114 | 17 | M149 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.31e-06 | 181 | 114 | 8 | M8187 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | TTF2 CENPE CEP290 TTF1 TFDP1 TFDP2 SPAG5 PAK2 SUZ12 TOP1 MYBL1 | 2.64e-06 | 426 | 114 | 11 | M9516 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SPAG5 MEN1 RTF1 KIF15 FAM32A CSNK1G3 MACO1 NFYC SUZ12 DDX21 DHX29 UTRN | 2.84e-06 | 519 | 114 | 12 | M3395 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | SPAG5 MEN1 RTF1 KIF15 FAM32A CSNK1G3 MACO1 NFYC SUZ12 DDX21 DHX29 UTRN | 4.50e-06 | 543 | 114 | 12 | MM997 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | TTF2 CENPE TTF1 TFDP1 TFDP2 SPAG5 NCBP2 PARP1 PA2G4 FAM76A SUZ12 TAF5 DDX21 TOP1 | 5.75e-06 | 761 | 114 | 14 | M11961 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | TPM2 KIF21B TTF2 CENPE TRAIP PCLO CCDC150 SPAG5 KIF15 SSX2IP TAF5 SKA3 | 6.97e-06 | 567 | 114 | 12 | M45692 |
| Coexpression | FAN_EMBRYONIC_CTX_NSC_2 | 8.47e-06 | 233 | 114 | 8 | M39036 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TPM3 TFDP3 LLPH TFDP1 SART1 GCC2 MACO1 WASF2 TAOK1 DHX29 GOLGA4 | 8.85e-06 | 484 | 114 | 11 | MM999 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | TTF2 WBP11 ERCC4 TTF1 TFDP1 PARP1 KIF15 SUDS3 PA2G4 SSX2IP NFYC PAK2 CKAP2 CDC5L TAF5 SKA3 DDX21 MYBL1 | 1.15e-05 | 1290 | 114 | 18 | M80 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 2.71e-05 | 199 | 114 | 7 | M9443 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | CCP110 TTF2 CENPE KIAA1586 TFDP1 SPAG5 KIF15 SSX2IP CKAP2 SKA3 | 2.79e-05 | 450 | 114 | 10 | M45747 |
| Coexpression | GABRIELY_MIR21_TARGETS | 3.97e-05 | 289 | 114 | 8 | M2196 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | CCP110 TTF2 ERCC4 CENPE TRAIP LLPH KIAA1586 TTF1 TFDP1 SPAG5 LRRC47 KIF15 SUZ12 CKAP2 TAF5 SKA3 BANK1 FILIP1L | 4.21e-05 | 1423 | 114 | 18 | M45722 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | TPM1 TTF2 CENPE TRAIP IFIT2 SPAG5 PA2G4 CKAP2 TAF5 SKA3 MYBL1 | 4.52e-05 | 578 | 114 | 11 | M2368 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL | 4.64e-05 | 478 | 114 | 10 | M45785 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_DN | 5.70e-05 | 48 | 114 | 4 | M521 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | CCP110 TTF2 CENPE TRAIP TTF1 TFDP1 SPAG5 KIF15 SUZ12 CKAP2 CDC5L TAF5 SKA3 NIN | 5.86e-05 | 939 | 114 | 14 | M45768 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | TPM1 TTF2 CENPE TRAIP IFIT2 SPAG5 PA2G4 CKAP2 TAF5 SKA3 MYBL1 | 6.04e-05 | 597 | 114 | 11 | MM1309 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CENPE IFIT2 NCBP2 CSNK1G3 SSX2IP PAK2 CKAP2 CDC5L SKA3 TOP1 AP3D1 MYBL1 | 7.31e-05 | 721 | 114 | 12 | M10237 |
| Coexpression | JI_RESPONSE_TO_FSH_DN | 8.43e-05 | 53 | 114 | 4 | M17537 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 8.65e-05 | 323 | 114 | 8 | M9150 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_F | 9.75e-05 | 55 | 114 | 4 | M2043 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 1.39e-04 | 180 | 114 | 6 | M2961 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | 1.43e-04 | 548 | 114 | 10 | M16859 | |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 1.52e-04 | 183 | 114 | 6 | M8189 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_MATURE_NK_T_CELL_AGEING | 1.69e-04 | 118 | 114 | 5 | MM3754 | |
| Coexpression | PUJANA_BRCA_CENTERED_NETWORK | 1.69e-04 | 118 | 114 | 5 | M15305 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 1.71e-04 | 187 | 114 | 6 | M2984 | |
| Coexpression | SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6 | 1.80e-04 | 458 | 114 | 9 | M8520 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 1.87e-04 | 190 | 114 | 6 | M761 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TTF2 TRAIP TFDP3 FAM227B TFDP1 PARP1 PA2G4 PDCD11 TAF5 SKA3 DDX21 DHX29 NIN | 1.90e-04 | 922 | 114 | 13 | MM1068 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.08e-04 | 467 | 114 | 9 | M1347 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_R848_DC_UP | 2.15e-04 | 195 | 114 | 6 | M4691 | |
| Coexpression | GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP | 2.34e-04 | 198 | 114 | 6 | M6168 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.34e-04 | 198 | 114 | 6 | M3195 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 2.39e-04 | 282 | 114 | 7 | MM3642 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP | 2.40e-04 | 199 | 114 | 6 | M8318 | |
| Coexpression | GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP | 2.40e-04 | 199 | 114 | 6 | M8301 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN | 2.40e-04 | 199 | 114 | 6 | M5366 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN | 2.40e-04 | 199 | 114 | 6 | M3175 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN | 2.40e-04 | 199 | 114 | 6 | M3197 | |
| Coexpression | GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP | 2.40e-04 | 199 | 114 | 6 | M6940 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 2.46e-04 | 200 | 114 | 6 | M5980 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP | 2.46e-04 | 200 | 114 | 6 | M9336 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.46e-04 | 200 | 114 | 6 | M302 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 2.46e-04 | 200 | 114 | 6 | M6647 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 2.46e-04 | 200 | 114 | 6 | M3446 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN | 2.46e-04 | 200 | 114 | 6 | M3635 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | 2.46e-04 | 200 | 114 | 6 | M3188 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 2.46e-04 | 200 | 114 | 6 | M5777 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 2.46e-04 | 200 | 114 | 6 | M5779 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_UP | 2.46e-04 | 200 | 114 | 6 | M3811 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.25e-04 | 75 | 114 | 4 | MM605 | |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 3.37e-04 | 137 | 114 | 5 | M406 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CENPE ERC1 RPS6KA3 GCC2 NFYC AFF1 SUZ12 DDX21 TOP1 GOLGA4 MYBL1 FILIP1L | 3.57e-04 | 856 | 114 | 12 | M4500 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | TPM1 TTF2 WBP11 RPS6KA3 RBM26 TFDP1 TFDP2 MEN1 MSN NCBP2 PARP1 CSNK1G3 EBAG9 CDC5L DDX21 TOP1 | 3.65e-04 | 1399 | 114 | 16 | M535 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | 3.82e-04 | 402 | 114 | 8 | M45754 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 3.82e-04 | 402 | 114 | 8 | MM454 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | TTF2 WBP11 CENPE SDCCAG8 CCDC150 LLPH SPAG5 NCBP2 KIF15 PA2G4 SSX2IP SUZ12 CKAP2 TAF5 SKA3 DDX21 | 3.89e-04 | 1407 | 114 | 16 | M14427 |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | GPI C9orf78 RTF1 NCBP2 SART1 PACS1 PARP1 FAM32A PA2G4 ARFGAP3 EBAG9 CDC5L DHX29 GOLGA4 | 3.95e-04 | 1129 | 114 | 14 | M42508 |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_DN | 3.99e-04 | 307 | 114 | 7 | M19745 | |
| Coexpression | BIDUS_METASTASIS_UP | 4.20e-04 | 221 | 114 | 6 | M15866 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 4.21e-04 | 408 | 114 | 8 | M11891 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | 4.71e-04 | 415 | 114 | 8 | MM1028 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 4.74e-04 | 316 | 114 | 7 | M2293 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | 4.83e-04 | 317 | 114 | 7 | M40298 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | GPI C9orf78 RTF1 NCBP2 SART1 PACS1 PARP1 FAM32A PA2G4 ARFGAP3 EBAG9 CDC5L DHX29 GOLGA4 | 5.08e-04 | 1158 | 114 | 14 | MM1338 |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 5.40e-04 | 323 | 114 | 7 | MM1066 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 5.48e-04 | 86 | 114 | 4 | M39248 | |
| Coexpression | BIDUS_METASTASIS_DN | 5.76e-04 | 154 | 114 | 5 | M8818 | |
| Coexpression | LEE_BMP2_TARGETS_DN | TTF2 TRAIP FAM227B TFDP1 PARP1 PA2G4 PDCD11 TAF5 SKA3 DDX21 DHX29 NIN | 5.79e-04 | 904 | 114 | 12 | M2325 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 5.93e-04 | 155 | 114 | 5 | M8944 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 5.93e-04 | 155 | 114 | 5 | M39041 | |
| Coexpression | ZHONG_PFC_C1_OPC | 6.20e-04 | 238 | 114 | 6 | M39096 | |
| Coexpression | FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION | 6.62e-04 | 9 | 114 | 2 | M16807 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM3 TTF2 WBP11 CENPE CEP85L KIF21A PCLO CEP290 LLPH SPAG5 KIF15 MACO1 TAOK1 SUZ12 TOP1 | 1.18e-07 | 532 | 111 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.88e-06 | 246 | 111 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TPM3 TTF2 CENPE CEP85L RPS6KA3 CEP290 LLPH SART1 KIF15 EBAG9 TOP1 RBM18 | 6.40e-06 | 469 | 111 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | CCP110 CENPE CEP85L ERC1 KIF21A CEP290 RBM26 CCDC122 KIF15 GCC2 NFYC AFF1 EBAG9 SUZ12 TOP1 RBM18 TOP2B MYBL1 FILIP1L | 2.49e-05 | 1252 | 111 | 19 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM3 CCP110 CENPE CEP85L KIF21A CEP290 RBM26 TTF1 SPAG5 MEN1 KIF15 GCC2 NFYC EBAG9 SUZ12 CDC5L TAF5 TOP1 MYBL1 | 2.63e-05 | 1257 | 111 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | SCRN3 CENPE ERC1 KIF21A PCLO CEP290 SPAG5 KIF15 NFYC EBAG9 EEA1 TOP1 GOLGA4 TOP2B MYBL1 | 2.80e-05 | 831 | 111 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.78e-05 | 311 | 111 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | CENPE DIS3L KIF21A PCLO SDCCAG8 CEP290 TFDP2 SPAG5 KIF15 GCC2 EBAG9 SUZ12 TOP1 TOP2B DEUP1 FILIP1L | 5.15e-05 | 983 | 111 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SCRN3 CENPE DIS3L ERC1 KIF21A CEP290 GCC2 NFYC EBAG9 EEA1 TOP1 RBM18 TOP2B NIN | 5.63e-05 | 780 | 111 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPM3 CCP110 CENPE CEP85L KIF21A CEP290 RBM26 TTF1 SPAG5 MEN1 KIF15 GCC2 NFYC EBAG9 SUZ12 CDC5L TAF5 TOP1 DEUP1 MYBL1 | 6.24e-05 | 1459 | 111 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 6.81e-05 | 192 | 111 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.47e-04 | 291 | 111 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CENPE DIS3L KIF21A PCLO PPP1R9A CEP290 TTF1 SPAG5 KIF15 EBAG9 SUZ12 TOP2B | 1.61e-04 | 654 | 111 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 2.20e-04 | 232 | 111 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CCP110 CENPE CEP85L RPS6KA3 CEP290 RBM26 CCDC122 SPAG5 KIF15 GCC2 EBAG9 SUZ12 CKAP2 TOP1 RBM18 TOP2B FILIP1L | 2.40e-04 | 1241 | 111 | 17 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | 2.45e-04 | 398 | 111 | 9 | GSM538338_500 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 2.45e-04 | 398 | 111 | 9 | GSM399397_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 2.49e-04 | 399 | 111 | 9 | GSM538345_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | CENPE DIS3L KIF21A PCLO CEP290 GCC2 UTRN TOP1 FILIP1L CCDC33 | 2.60e-04 | 492 | 111 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.64e-04 | 493 | 111 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | 3.82e-04 | 423 | 111 | 9 | GSM476655_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 3.90e-04 | 255 | 111 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.24e-04 | 429 | 111 | 9 | gudmap_developingGonad_e14.5_ testes_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.21e-04 | 192 | 111 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | CCP110 TTF2 CENPE TRAIP CCDC150 SPAG5 KIF15 CKAP2 SKA3 MYBL1 | 1.14e-10 | 199 | 115 | 10 | 98575fcce726589e93fbb4df1aab03e57cb56076 |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-10 | 178 | 115 | 9 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-09 | 191 | 115 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.54e-09 | 199 | 115 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-08 | 163 | 115 | 8 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-08 | 169 | 115 | 8 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-08 | 174 | 115 | 8 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-08 | 180 | 115 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-08 | 182 | 115 | 8 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-08 | 182 | 115 | 8 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-08 | 184 | 115 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-08 | 184 | 115 | 8 | 8f40093de5bb978f046d66e8f05f333686a009a4 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.37e-08 | 189 | 115 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-08 | 191 | 115 | 8 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-08 | 191 | 115 | 8 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.81e-08 | 192 | 115 | 8 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.81e-08 | 192 | 115 | 8 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-08 | 127 | 115 | 7 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.64e-08 | 197 | 115 | 8 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | distal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.83e-08 | 198 | 115 | 8 | a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.02e-08 | 199 | 115 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.02e-08 | 199 | 115 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.02e-08 | 199 | 115 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-08 | 200 | 115 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-08 | 200 | 115 | 8 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.22e-08 | 200 | 115 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.22e-08 | 200 | 115 | 8 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-07 | 158 | 115 | 7 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-07 | 166 | 115 | 7 | 21ba5fd755c0fb31ada42a1b5d60bede0153323d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-07 | 171 | 115 | 7 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.53e-07 | 174 | 115 | 7 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.53e-07 | 174 | 115 | 7 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-07 | 175 | 115 | 7 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-07 | 176 | 115 | 7 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-07 | 179 | 115 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.44e-07 | 180 | 115 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 182 | 115 | 7 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-07 | 184 | 115 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.34e-07 | 185 | 115 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-07 | 185 | 115 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-07 | 185 | 115 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 186 | 115 | 7 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-07 | 186 | 115 | 7 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-07 | 187 | 115 | 7 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-07 | 116 | 115 | 6 | cf4e3c34570f57502ec524881d351ef8e47976d2 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.95e-07 | 188 | 115 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.39e-07 | 190 | 115 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.62e-07 | 191 | 115 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.62e-07 | 191 | 115 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.62e-07 | 191 | 115 | 7 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.86e-07 | 192 | 115 | 7 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-07 | 192 | 115 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.86e-07 | 192 | 115 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.10e-07 | 193 | 115 | 7 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.10e-07 | 193 | 115 | 7 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.10e-07 | 193 | 115 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-07 | 194 | 115 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.35e-07 | 194 | 115 | 7 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.61e-07 | 195 | 115 | 7 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 7.61e-07 | 195 | 115 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.61e-07 | 195 | 115 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.61e-07 | 195 | 115 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 7.88e-07 | 196 | 115 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.88e-07 | 196 | 115 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 7.88e-07 | 196 | 115 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.88e-07 | 196 | 115 | 7 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-07 | 197 | 115 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-07 | 197 | 115 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-07 | 197 | 115 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-07 | 197 | 115 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.15e-07 | 197 | 115 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.43e-07 | 198 | 115 | 7 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.43e-07 | 198 | 115 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytokine_secreting_effector_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.43e-07 | 198 | 115 | 7 | 34c564ece9a2b94dcf646e3c95b5be9c5ecfaafe | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.43e-07 | 198 | 115 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 8.43e-07 | 198 | 115 | 7 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.43e-07 | 198 | 115 | 7 | 281fc2536cdc4c717b30de156e563c0e4baba99d | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.72e-07 | 199 | 115 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 8.72e-07 | 199 | 115 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.02e-07 | 200 | 115 | 7 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells-Neuroepithelial_cell|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | c88d8e67647c90d1fa2569516865a9fd766eaf1c | |
| ToppCell | severe-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.02e-07 | 200 | 115 | 7 | 2253d74049cc49c92e897ff4aa298d913daeb739 | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 9.02e-07 | 200 | 115 | 7 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 9.02e-07 | 200 | 115 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | 28935053cd6918cd2e9f3e7691f8522216585cb6 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.02e-07 | 200 | 115 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 129 | 115 | 6 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-06 | 130 | 115 | 6 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 154 | 115 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 154 | 115 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.34e-06 | 164 | 115 | 6 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 4.81e-06 | 167 | 115 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.81e-06 | 167 | 115 | 6 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-06 | 167 | 115 | 6 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-06 | 168 | 115 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-06 | 168 | 115 | 6 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-06 | 168 | 115 | 6 | faaba5ac01c2ebe380f56559374a121979a85a13 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-06 | 169 | 115 | 6 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-06 | 169 | 115 | 6 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| Drug | amphidinolide D | 1.25e-06 | 5 | 115 | 3 | CID006439238 | |
| Drug | eudistomin M | 1.25e-06 | 5 | 115 | 3 | CID000145927 | |
| Drug | didansylcystine | 2.48e-06 | 6 | 115 | 3 | CID000167721 | |
| Drug | Topanol Ca | 4.33e-06 | 7 | 115 | 3 | CID000092905 | |
| Drug | CP-31 | 1.03e-05 | 9 | 115 | 3 | CID000452624 | |
| Drug | purealin | 1.11e-05 | 58 | 115 | 5 | CID006419303 | |
| Drug | IASL | 1.47e-05 | 10 | 115 | 3 | CID002724305 | |
| Drug | damnacanthol | 2.53e-05 | 2 | 115 | 2 | CID000160474 | |
| Drug | methyl brevifolincarboxylate | 2.53e-05 | 2 | 115 | 2 | CID005319518 | |
| Drug | AC1NSWD2 | 2.53e-05 | 2 | 115 | 2 | CID005318091 | |
| Drug | AC1L2J0B | 2.53e-05 | 2 | 115 | 2 | CID000072943 | |
| Drug | rubiadin-1-methyl ether | 2.53e-05 | 2 | 115 | 2 | CID000096191 | |
| Drug | A 62176 | 2.53e-05 | 2 | 115 | 2 | CID000132823 | |
| Drug | Kt 6528 | 2.53e-05 | 2 | 115 | 2 | CID000132714 | |
| Drug | AC1NRD2N | 2.67e-05 | 12 | 115 | 3 | CID005289322 | |
| Drug | TMBr-3 | 3.46e-05 | 13 | 115 | 3 | CID000518955 | |
| Drug | AC1MP21W | 4.39e-05 | 14 | 115 | 3 | CID003378340 | |
| Drug | goniodomin A | 4.39e-05 | 14 | 115 | 3 | CID006440832 | |
| Drug | A-G-T-C | 5.46e-05 | 15 | 115 | 3 | CID003037868 | |
| Drug | conen | 5.46e-05 | 15 | 115 | 3 | CID000093117 | |
| Drug | AC1L1D59 | 6.29e-05 | 266 | 115 | 8 | CID000002199 | |
| Drug | polyporenic acid C | 7.56e-05 | 3 | 115 | 2 | CID005320667 | |
| Drug | DABMI | 8.11e-05 | 17 | 115 | 3 | CID000137371 | |
| Disease | Cap Myopathy | 3.83e-05 | 3 | 106 | 2 | C3710589 | |
| Disease | FANCONI ANEMIA, COMPLEMENTATION GROUP Q | 7.63e-05 | 4 | 106 | 2 | C3808988 | |
| Disease | Digitotalar Dysmorphism | 1.90e-04 | 6 | 106 | 2 | C1852085 | |
| Disease | Congenital myopathy with fiber type disproportion | 1.90e-04 | 6 | 106 | 2 | cv:C0546264 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 1.90e-04 | 6 | 106 | 2 | C0220662 | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 2B | 1.90e-04 | 6 | 106 | 2 | C1834523 | |
| Disease | Intellectual Disability | 2.15e-04 | 447 | 106 | 8 | C3714756 | |
| Disease | post-traumatic stress disorder symptom measurement | 2.22e-04 | 82 | 106 | 4 | EFO_0008535 | |
| Disease | Nemaline Myopathy, Childhood Onset | 2.65e-04 | 7 | 106 | 2 | C0546125 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 2.65e-04 | 7 | 106 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 2.65e-04 | 7 | 106 | 2 | cv:C0403553 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 3.20e-04 | 37 | 106 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Myopathies, Nemaline | 3.53e-04 | 8 | 106 | 2 | C0206157 | |
| Disease | Nemaline myopathy | 3.53e-04 | 8 | 106 | 2 | cv:C0206157 | |
| Disease | Distal arthrogryposis | 4.53e-04 | 9 | 106 | 2 | cv:C0265213 | |
| Disease | PITUITARY DWARFISM I | 4.53e-04 | 9 | 106 | 2 | C0342573 | |
| Disease | Situs ambiguous | 4.53e-04 | 9 | 106 | 2 | C1167664 | |
| Disease | Malignant neoplasm of breast | GPI MYH1 CEP85L SYNE1 RPS6KA3 PARP1 ARFGAP3 NFYC MROH7 AFF1 DNAH9 TOP1 | 4.82e-04 | 1074 | 106 | 12 | C0006142 |
| Disease | cystic kidney disease (implicated_via_orthology) | 5.65e-04 | 10 | 106 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | ureteral obstruction (biomarker_via_orthology) | 5.73e-04 | 45 | 106 | 3 | DOID:5199 (biomarker_via_orthology) | |
| Disease | Situs Inversus | 6.88e-04 | 11 | 106 | 2 | C0037221 | |
| Disease | Renal dysplasia and retinal aplasia (disorder) | 8.24e-04 | 12 | 106 | 2 | C0403553 | |
| Disease | Congenital myopathy (disorder) | 8.24e-04 | 12 | 106 | 2 | C0270960 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 9.72e-04 | 13 | 106 | 2 | C3661489 | |
| Disease | Alzheimer disease, cognitive decline measurement, Cognitive impairment | 9.72e-04 | 13 | 106 | 2 | EFO_0007710, HP_0100543, MONDO_0004975 | |
| Disease | Centronuclear myopathy | 9.72e-04 | 13 | 106 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 9.72e-04 | 13 | 106 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 9.72e-04 | 13 | 106 | 2 | C4551952 | |
| Disease | Bardet-Biedl Syndrome | 9.72e-04 | 13 | 106 | 2 | C0752166 | |
| Disease | Congenital Structural Myopathy | 9.72e-04 | 13 | 106 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.13e-03 | 14 | 106 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.13e-03 | 14 | 106 | 2 | C0410207 | |
| Disease | Situs ambiguus | 1.30e-03 | 15 | 106 | 2 | C0266642 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.30e-03 | 15 | 106 | 2 | C3645536 | |
| Disease | Arsenic Induced Polyneuropathy | 1.46e-03 | 62 | 106 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 1.46e-03 | 62 | 106 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 1.46e-03 | 62 | 106 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 1.46e-03 | 62 | 106 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 1.46e-03 | 62 | 106 | 3 | C0274862 | |
| Disease | pulse pressure measurement | TPM1 SDCCAG8 LLPH CCDC141 KIF15 CSNK1G3 WASF2 SYT1 AP3D1 BICC1 GOLGA4 FILIP1L NIN | 1.46e-03 | 1392 | 106 | 13 | EFO_0005763 |
| Disease | Blood Platelet Disorders | 1.48e-03 | 16 | 106 | 2 | C0005818 | |
| Disease | Congenital Fiber Type Disproportion | 1.88e-03 | 18 | 106 | 2 | C0546264 | |
| Disease | Bardet-Biedl syndrome | 1.88e-03 | 18 | 106 | 2 | cv:C0752166 | |
| Disease | Chronic myeloproliferative disorder | 2.10e-03 | 19 | 106 | 2 | C1292778 | |
| Disease | Testicular Germ Cell Tumor | 2.33e-03 | 73 | 106 | 3 | EFO_1000566 | |
| Disease | unipolar depression, bipolar disorder | 2.46e-03 | 156 | 106 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | Seckel syndrome | 2.82e-03 | 22 | 106 | 2 | C0265202 | |
| Disease | blood pressure | 2.82e-03 | 22 | 106 | 2 | EFO_0004325 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.03e-03 | 80 | 106 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | exploratory eye movement measurement | 3.14e-03 | 81 | 106 | 3 | EFO_0007700 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLPLLKEKLEKMMEK | 831 | Q15361 | |
| KVKNGKMSMDEALEK | 686 | Q8NDB2 | |
| KKKIMLSDEMETEKN | 131 | Q96M60 | |
| MKEEKVASLMLKEAL | 236 | Q5FYA8 | |
| EAKRAAKMEKKMKIL | 706 | Q99459 | |
| MKKDEKMNISGKKNV | 286 | Q9NP61 | |
| IQMLKMKEAKKVVII | 121 | A6NEN9 | |
| KKEILLAMLMVDKEK | 126 | Q96GE6 | |
| MKQKLLLSELDMKKL | 691 | Q8N5R6 | |
| VMNKKDKKIAMDILN | 216 | Q9Y2D8 | |
| ELKKVLQQMKKEMIS | 276 | Q9Y2D8 | |
| KQLKMELEIKEKMLA | 396 | Q05D60 | |
| SKPKKEEKNMEVNMK | 216 | Q7Z478 | |
| KKEDVKEAKEMIMSV | 111 | Q9H694 | |
| MKKSQREDIFKKMSE | 1 | Q6DHV5 | |
| GMVSKKNLMEIVKKL | 366 | O14617 | |
| VLKLKTKMADKENMK | 71 | Q8WWK9 | |
| AEGEKKTMIKKIMRQ | 451 | Q68CQ1 | |
| KKMEKEAQRLMKKEQ | 191 | O00559 | |
| AKIKAIEAKLKMMAE | 141 | Q96H35 | |
| KNKTMKSEDKAEIMK | 761 | Q5T8P6 | |
| MEKVKQELESMKAKL | 881 | Q8IUD2 | |
| KAKLLREMMAKIEDK | 376 | Q9H3S7 | |
| STKKEVEKMNKKMEE | 431 | P09874 | |
| QIKELADTTAMKKIM | 236 | Q6ZRR7 | |
| EKMKGMKELLVATKI | 561 | O00255 | |
| IEKMLKIKKIMDNVL | 1361 | Q8N7Z5 | |
| IMEETGKIFKKEKEM | 56 | Q9UQ80 | |
| KMKQRILKEDMLKIV | 56 | Q9BZ81 | |
| KSKIVEEMLKMKADL | 1256 | Q9NS87 | |
| IKKIIMGLDKMKKTA | 66 | P52298 | |
| MEKVKQKAKEMQETL | 956 | Q13439 | |
| KDRKETMTMILKAKL | 271 | P51812 | |
| LKMAEMKKYTLENKE | 501 | Q8N1G4 | |
| DDMKMETDIKRNKKT | 71 | Q9BRT6 | |
| EGKKLTMDMKVKEDQ | 516 | Q8N5G2 | |
| QVMGEIKIALKKEMK | 5006 | Q9Y6V0 | |
| AKEMKMKIFKNIIEE | 296 | Q9HCI6 | |
| EVAEMKKAKVALMKQ | 751 | O75037 | |
| AMLENEKKKREMAEK | 321 | P26038 | |
| MREEKKMQEQEKKTR | 426 | Q8N9W4 | |
| KDVMPEVNKVLDKMK | 116 | P06744 | |
| RVKQKLEKEKSEMKM | 1216 | P12882 | |
| MENKKKDKDKSDDRM | 1 | Q9Y6M4 | |
| ARIKKIMKLDEDVKM | 46 | Q13952 | |
| KKLVMLKEMDKDLNS | 126 | Q6VY07 | |
| QKKKTKMTDEEIMEK | 221 | Q13177 | |
| DKMVKKIAMREIKLL | 41 | Q92772 | |
| MQLKKETIEEKKDRM | 116 | Q96M91 | |
| LQKVKMEKEALMTEL | 841 | Q15075 | |
| VLKEKMAQMSSLVEK | 1056 | B1AJZ9 | |
| AEKMQALKRKMEKVS | 951 | Q6ZP82 | |
| MKQIEKELKQMELIK | 916 | Q8NCX0 | |
| RDFVKKLKTMKEELM | 156 | Q5T0U0 | |
| DIVSISKKITMLEMK | 1051 | O15078 | |
| SKKITMLEMKELNER | 1056 | O15078 | |
| KLKLKDMKAIEDDLM | 636 | Q4L180 | |
| EKMQEKRQMERILKK | 66 | Q9Y421 | |
| LMAAISKDKKMEIKG | 811 | Q8TF46 | |
| KKQLQMKMCALEEEK | 91 | Q6ZRK6 | |
| KLLLEKKRSEVMKMK | 2571 | Q8WXX0 | |
| PKEDLIKFAKKQMML | 26 | Q8IWJ2 | |
| LEKLMVQMKVLSEDK | 666 | Q8IWJ2 | |
| FKSVEKKMTDMLKEE | 371 | Q5T5S1 | |
| KEKLTTQKMMEELEK | 646 | Q5SZL2 | |
| EEQEKMLKEKKAMTA | 686 | O43303 | |
| MKDKLQKIAKMRLSK | 411 | P09913 | |
| KTIELQMKKKGFKME | 306 | P04839 | |
| TKKMDKTAKLDLLMQ | 526 | Q9GZR7 | |
| KAAKEMGMEKTLKEL | 1426 | Q9NYC9 | |
| KKMKKEKEMNGETRE | 131 | Q9NR30 | |
| KLEMAMKELSTLKKK | 126 | Q68D86 | |
| KMKLVKIDLEKMKNA | 2461 | Q02224 | |
| KKIKELEMLLMSAEN | 266 | P10243 | |
| MKKTQLLKEKAMAED | 511 | Q92541 | |
| AINMKDVKDLGKTMK | 101 | P21579 | |
| ELKDSDKLDKIMNMK | 431 | Q15542 | |
| DKLDKIMNMKETTKR | 436 | Q15542 | |
| MQDTSEMKKKLKALE | 721 | P46939 | |
| AQKMMKKKKEAEDVA | 231 | Q9C093 | |
| LEIAKVMKEEMKRIK | 736 | P0C7P3 | |
| KLRVMFLEMKNEKEK | 1121 | Q96R06 | |
| FLEMKNEKEKLMIKF | 1126 | Q96R06 | |
| KFKMEKLDKDIVALM | 246 | Q02880 | |
| MMIKELKLQILKSSK | 666 | P12757 | |
| LLSVKQEKEIQMKMI | 3326 | Q8NF91 | |
| DKVDTVMMGKKLKTL | 3736 | Q8NF91 | |
| LKKKQVKLDEQLMEM | 1946 | Q8N4C6 | |
| MKAMKKESEGLKLVK | 386 | Q8IVG5 | |
| RAIEKDMMKKEITKE | 386 | Q86SQ7 | |
| KAKIMLDNMRKLEKE | 366 | Q0VDG4 | |
| MEKLIKKHQAAMEKE | 511 | Q7L7X3 | |
| AMEKEAKVMSNEEKK | 521 | Q7L7X3 | |
| MLHQKDQMILEKEKK | 231 | Q8TAV0 | |
| EFQKILDFMKDVMKK | 171 | P20701 | |
| LMAMNIISKEKKEIK | 191 | Q14188 | |
| DKMKLIVEVKMRKQA | 421 | Q5VX52 | |
| KDLMLEEKNKKLMNE | 66 | Q8NF67 | |
| AKKMKQKAELMTDRV | 971 | P51825 | |
| IKATKVLMEKNSMDI | 76 | Q8IX90 | |
| KLMMTLKKTLIESKL | 516 | Q14690 | |
| LMAMNIISKEKKEIK | 176 | Q14186 | |
| KNLLQKIDMDSKMKK | 641 | Q8IVF5 | |
| KMKVIKTMEAISEVL | 176 | Q96EN9 | |
| LKKLQQDVMEMKKTK | 756 | Q7Z4S6 | |
| FVKEEAALMRKKMAK | 531 | Q5TF21 | |
| AALMRKKMAKIDKEK | 536 | Q5TF21 | |
| TFKVDDMLSKVEKMK | 131 | Q15022 | |
| RMKKLDEEALLKKMS | 746 | O43290 | |
| LMAMNIISREKKKIK | 171 | Q5H9I0 | |
| KEKMLQDTKDIMKEK | 161 | Q9Y6W5 | |
| KKMQMLKLDKENALD | 6 | P09493 | |
| MVDMKKLKERGKDKI | 76 | Q9NZ63 | |
| MSKKEKISEKMEIKE | 351 | Q92889 | |
| KMKDPKQIIRDMEKL | 46 | Q9Y2W2 | |
| EKKKMIENEKLTMEL | 156 | Q9H7L9 | |
| KKMQMLKLDKENAID | 6 | P07951 | |
| VMLKDTDMNKKDKQK | 196 | Q6S545 | |
| EKSMMNLQTKIDAKK | 641 | P11387 | |
| KKKMQMLKLDKENAL | 6 | P06753 | |
| KKEQKPEMMEKDLSS | 166 | Q9UNY4 | |
| DKEIMSLKKKLTMLQ | 261 | Q9BWF2 | |
| KMIQEKKEQAEMKRK | 806 | Q8IZF0 | |
| QDRAVVKKKLKEMKM | 1036 | Q9ULJ8 | |
| KEMKMSLEKARKAQE | 1046 | Q9ULJ8 |